We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q4 Earnings
Read MoreHide Full Article
Analysts on Wall Street project that HealthEquity (HQY - Free Report) will announce quarterly earnings of $0.55 per share in its forthcoming report, representing an increase of 48.7% year over year. Revenues are projected to reach $258.43 million, increasing 10.5% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific HealthEquity metrics that are routinely monitored and predicted by Wall Street analysts.
The average prediction of analysts places 'Revenue- Service revenue' at $112.95 million. The estimate suggests a change of -1.1% year over year.
The consensus among analysts is that 'Revenue- Custodial revenue' will reach $108.06 million. The estimate points to a change of +29.4% from the year-ago quarter.
The consensus estimate for 'Revenue- Interchange revenue' stands at $36.32 million. The estimate indicates a year-over-year change of +0.6%.
Based on the collective assessment of analysts, 'Total HSA Assets' should arrive at $24.25 billion. The estimate is in contrast to the year-ago figure of $22.15 billion.
Analysts predict that the 'Total HSA investments' will reach $9.06 billion. The estimate is in contrast to the year-ago figure of $7.95 billion.
Analysts forecast 'HSAs Accounts' to reach 2,168.90 million. Compared to the present estimate, the company reported 7.98 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Total Accounts' of 15,502.88 thousand. The estimate compares to the year-ago value of 14,917 thousand.
HealthEquity shares have witnessed a change of +3% in the past month, in contrast to the Zacks S&P 500 composite's +4.4% move. With a Zacks Rank #3 (Hold), HQY is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q4 Earnings
Analysts on Wall Street project that HealthEquity (HQY - Free Report) will announce quarterly earnings of $0.55 per share in its forthcoming report, representing an increase of 48.7% year over year. Revenues are projected to reach $258.43 million, increasing 10.5% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific HealthEquity metrics that are routinely monitored and predicted by Wall Street analysts.
The average prediction of analysts places 'Revenue- Service revenue' at $112.95 million. The estimate suggests a change of -1.1% year over year.
The consensus among analysts is that 'Revenue- Custodial revenue' will reach $108.06 million. The estimate points to a change of +29.4% from the year-ago quarter.
The consensus estimate for 'Revenue- Interchange revenue' stands at $36.32 million. The estimate indicates a year-over-year change of +0.6%.
Based on the collective assessment of analysts, 'Total HSA Assets' should arrive at $24.25 billion. The estimate is in contrast to the year-ago figure of $22.15 billion.
Analysts predict that the 'Total HSA investments' will reach $9.06 billion. The estimate is in contrast to the year-ago figure of $7.95 billion.
Analysts forecast 'HSAs Accounts' to reach 2,168.90 million. Compared to the present estimate, the company reported 7.98 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Total Accounts' of 15,502.88 thousand. The estimate compares to the year-ago value of 14,917 thousand.
View all Key Company Metrics for HealthEquity here>>>
HealthEquity shares have witnessed a change of +3% in the past month, in contrast to the Zacks S&P 500 composite's +4.4% move. With a Zacks Rank #3 (Hold), HQY is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>